MUFG Securities EMEA’s Audentes Therapeutics BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-190,000
Closed -$11.4M – 581
2019
Q4
$11.4M Buy
+190,000
New +$7.13M 0.09% 188

MUFG Securities EMEA's BOLD Position: Q1 2020 in Review

MUFG Securities EMEA sold out of Audentes Therapeutics (BOLD) in Q1 2020, closing a stake of 190,000 shares — an estimated $11.4M sold.

MUFG Securities EMEA first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $11.4M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • MUFG Securities EMEA reported no remaining Audentes Therapeutics position as of Q1 2020 after selling out during the quarter.
  • MUFG Securities EMEA sold 190,000 Audentes Therapeutics shares in Q1 2020, an estimated $11.4M.
  • MUFG Securities EMEA first reported a position in Audentes Therapeutics in Q4 2019 and held it in 1 quarter.
  • MUFG Securities EMEA's Audentes Therapeutics position peaked at $11.4M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics as of Q1 2020.

Based on MUFG Securities EMEA's 13F filing for Q1 2020, filed 12 May 2020.